A Fresh insight into why the United States (U.S.) rejected
Nigeria’s request for the experimental Ebola drug ZMapp emerged Thursday. The
U.S. Assistant Secretary of State for African Affairs, Linda Thomas Greenfield,
explained that Nigeria’s request was not met because there were only six doses
of the drug and that they had all been used. Greenfield spoke when she visited
the Minister of Health, Prof. Onyebuchi Chukwu, in Abuja yesterday. She said:
The Centre for Disease Control has proactively supported all the countries in
the West African region in dealing with the situation. It is not about ZMapp.
There were six doses of ZMapp available. They were all used. What is important
is how to control the spread of the disease. And that is exactly what is being
done here in Nigeria, and efforts are being made to have the same kind of
success in Liberia. On her appraisal of other countries in the region affected
by the virus, she said: We are very concerned about the spread of the Ebola
disease in Liberia, Sierra Leone and in Guinea. Efforts have been made
proactively, every single day, with the support of the Centre for Disease
Control, the World Health Organisation and the medical community around the
continent of African and around the world to support the efforts to contain the
outbreaks in these countries. Again, I really commend everything that is being
done here in Nigeria to contain the outbreak.
Guardian Newspaper
No comments:
Post a Comment